NDC Package 70518-1804-1 Doxazosin

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70518-1804-1
Package Description:
90 TABLET in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Doxazosin
Non-Proprietary Name:
Doxazosin
Substance Name:
Doxazosin Mesylate
Usage Information:
Doxazosin is used alone or with other drugs to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This medication works by relaxing blood vessels so blood can flow more easily. Doxazosin is also used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It does not shrink the prostate, but it works by relaxing the muscles in the prostate and part of the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate frequently or urgently (including during the middle of the night). Doxazosin belongs to a class of drugs known as alpha blockers.
11-Digit NDC Billing Format:
70518180401
NDC to RxNorm Crosswalk:
  • RxCUI: 197627 - doxazosin mesylate 4 MG Oral Tablet
  • RxCUI: 197627 - doxazosin 4 MG Oral Tablet
  • RxCUI: 197627 - doxazosin (as doxazosin mesylate) 4 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Remedyrepack Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA202824
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-17-2019
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70518-1804-1?

    The NDC Packaged Code 70518-1804-1 is assigned to a package of 90 tablet in 1 bottle, plastic of Doxazosin, a human prescription drug labeled by Remedyrepack Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 70518-1804 included in the NDC Directory?

    Yes, Doxazosin with product code 70518-1804 is active and included in the NDC Directory. The product was first marketed by Remedyrepack Inc. on January 17, 2019 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70518-1804-1?

    The 11-digit format is 70518180401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-170518-1804-15-4-270518-1804-01